BioSpace News Archive

Biotech Beach

NKMax America Announces Executive Advisory Board

NKMax America, a biotechnology company harnessing the power of the body’s immune system through the development of Natural Killer (NK) cell therapies, today announced that it has brought together an unparalleled group of thought leaders to provide expertise to the NKMax senior leadership team.

November 11, 2019
·
4 min read
Job Trends

Global Design Contest Awards ULiSSES™ Medical Device Grand Prize

ULiSSES™, a first-of-its-kind medical device, created by Vascular Perfusion Solutions, Inc. has been selected as the Grand Prize winner in the 2019 “Create the Future” Design Contest.

November 11, 2019
·
3 min read
Biotech Beach

The Ensign Group to Present at the Stephens Nashville Investment Conference on November 14, 2019

The Ensign Group, Inc., the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, and assisted living companies, announced that it will participate in the Stephens Nashville Investment Conference on November 14, 2019.

November 11, 2019
·
3 min read
Drug Development

Lupus Research Alliance Response to Positive Data from Phase 3 Anifrolumab Trial Presented at 2019 ACR/ARP Annual Meeting

The Lupus Research Alliance (LRA) congratulates AstraZeneca on new positive results from the Phase 3 TULIP-2 trial (Treatment of Uncontrolled Lupus via the Interferon Pathway) just presented at the 2019 ACR/ARP Annual Meeting.

November 11, 2019
·
4 min read
Business

Survey: More than Half of Male Patients with Lupus Report Feeling Depressed, Receiving Little Support

A national survey of male patients with lupus finds the illness has a significant impact on their physical and emotional health, yet they often do not receive support that could help them cope.

November 11, 2019
·
6 min read
Pharm Country

New Analysis Shows Icosapent Ethyl (Vascepa®) Is Cost Effective and Offers Rare Finding of Better Outcomes at Lower Healthcare Costs When Used to Treat High-Risk Patients with Cardiovascular Disease or Diabetes and Other Risk Factors

Amarin Corporation plc (NASDAQ: AMRN) announced today a summary of results from a patient-level, cost-effectiveness analysis of icosapent ethyl (Vascepa®)

November 11, 2019
·
16 min read
Drug Development

Mallinckrodt Presents Positive Phase 3 Results from its CONFIRM Study of Terlipressin in Patients with Hepatorenal Syndrome Type 1 (HRS-1) at The Liver Meeting® 2019

The CONFIRM abstract was selected by the AASLD Selection Committee for the “Best of the Liver Meeting” educational program in the portal hypertension / cirrhosis category

November 11, 2019
·
10 min read
Business

SI-BONE, Inc. Reports Third Quarter 2019 Financial Results and Updates Full-Year 2019 Revenue Guidance

SI-BONE, Inc., a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, reported financial results for the quarter ended September 30, 2019.

November 11, 2019
·
5 min read
Deals

Reata Announces Positive Topline Year One Results From Pivotal Phase 3 Cardinal Study of Bardoxolone Methyl in Patients With Alport Syndrome

Achieved key secondary endpoint of statistically significant improvement in retained EGFR compared to placebo after 48 weeks of treatment and withdrawal of drug for 4 weeks

November 11, 2019
·
11 min read
Business

Rockwell Medical, Inc. Reports Third Quarter 2019 Financial Results

Company reports first full quarter of results for Dialysate Triferic, highlighted by greater than 75% conversion rate from Triferic Evaluation Program

November 11, 2019
·
12 min read